(Q55466879)

12 July 2018

title

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. (English)

1 reference

12 July 2018

1 reference

neoplastic stem cells

1 reference

2

Jörg Wischhusen

1 reference

12 July 2018

Dagmar Beier

1

1 reference

12 July 2018

Wolfgang Dietmaier

3

1 reference

12 July 2018

Peter Hau

4

1 reference

12 July 2018

Martin Proescholdt

5

1 reference

12 July 2018

Alexander Brawanski

6

1 reference

12 July 2018

Ulrich Bogdahn

7

1 reference

12 July 2018

Christoph P Beier

8

1 reference

12 July 2018

publication date

26 March 2008

1 reference

12 July 2018

published in

Brain Pathology

1 reference

12 July 2018

volume

18

1 reference

12 July 2018

page(s)

370-377

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Successful chemotherapy for recurrent malignant oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Self-renewal and solid-tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Glial progenitors in the CNS and possible lineage relationships among them

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Pathology and molecular genetics of astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00130.X

10.1111/J.1750-3639.2008.00130.X

21 January 2018

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

18371181

1 reference

12 July 2018